No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls

Molecular and Cellular Probes

Volumn 25, Issue 2-3, 2011, Pages 134-136

  Sabunciyan, Sarven ^a,b   Mandelberg, Nataniel ^a   Rabkin, Charles S ^c   Yolken, Robert ^a   Viscidi, Raphael ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ELISA; Epidemiology; Prostate cancer; Virus; Xenotropic murine leukemia Virus related virus; XMRV

Indexed keywords

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES; XENOTROPIC MULV RELATED VIRUS;

ANTIBODIES, VIRAL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE PRODUCTS, ENV; HUMANS; MALE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE INFECTIONS; SENSITIVITY AND SPECIFICITY; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

GAMMARETROVIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 79955483491     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2011.01.005     Document Type: Article

References (7)

1. Casey G., Neville P.J., Plummer S.J., Xiang Y., Krumroy L.M., Klein E.A., et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002, 32:581-583.
2. Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2:e25.
3. Dong B., Kim S., Hong S., Das Gupta J., Malathi K., Klein E.A., et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007, 104:1655-1660.
4. Schlaberg R., Choe D.J., Brown K.R., Thaker H.M., Singh I.R. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 2009, 106:16351-16356.
5. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, et al. XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 75:755-761.
6. Hohn O., Krause H., Barbarotto P., Niederstadt L., Beimforde N., Denner J., et al. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009, 6:92.
7. DiMagno E.P., Corle D., O'Brien J.F., Masnyk I.J., Go V.L., Aamodt R. Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 1989, 64:1226-1234.